These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
119 results:

  • 1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
    Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
    Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
    [No Abstract]    [Full Text] [Related]  

  • 2. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
    Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
    Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    Stubbins RJ; Korotev S; Godley LA
    Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Kayabasi C; Yilmaz Susluer S; Balci Okcanoglu T; Ozmen Yelken B; Mutlu Z; Goker Bagca B; Caliskan Kurt C; Saydam G; Durmuskahya C; Kayalar H; Ozbilgin A; Biray Avci C; Gunduz C
    Nutr Cancer; 2022; 74(10):3679-3691. PubMed ID: 35608652
    [No Abstract]    [Full Text] [Related]  

  • 5. Classic myeloproliferative neoplasms in Singapore: A population-based study on incidence, trends, and survival from 1968 to 2017.
    Htun HL; Lian W; Wong J; Tan EJ; Foo LL; Ong KH; Lim WY
    Cancer Epidemiol; 2022 Aug; 79():102175. PubMed ID: 35569302
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patient-Derived In Vitro and In Vivo Models of Cancer.
    Claridge SE; Cavallo JA; Hopkins BD
    Adv Exp Med Biol; 2022; 1361():215-233. PubMed ID: 35230691
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Rapid and non-invasive discrimination of acute leukemia bone marrow supernatants by Raman spectroscopy and multivariate statistical analysis.
    Liang H; Cheng X; Dong S; Wang H; Liu E; Ru Y; Li Y; Kong X; Gao Y
    J Pharm Biomed Anal; 2022 Feb; 210():114560. PubMed ID: 34999436
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors.
    Rimondi E; Melloni E; Romani A; Tisato V; Casciano F; Rigolin GM; Milani D; Celeghini C; Zauli G; Secchiero P; Voltan R
    Curr Oncol; 2021 Jul; 28(4):2439-2451. PubMed ID: 34287267
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease.
    Mehta RS; Saliba RM; Jan A; Shigle TL; Wang E; Nieto Y; Ciurea SO; Oran B; Im J; Olson A; Marin D; Qazilbash M; Khouri I; Rondon G; Anderlini P; Rezvani K; Popat U; Kebriaei P; Shpall E; Champlin R; Alousi A
    Transplant Cell Ther; 2021 Mar; 27(3):272.e1-272.e5. PubMed ID: 33781539
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Axolotl
    Suleiman S; Di Fiore R; Cassar A; Formosa MM; Schembri-Wismayer P; Calleja-Agius J
    Tumour Biol; 2020 Sep; 42(9):1010428320954735. PubMed ID: 32873193
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anticancer effects of an extract from a local planarian species on human acute myeloid leukemia HL-60 cells in vitro.
    Suleiman S; Di Fiore R; Cassar A; Formosa MM; Calleja-Agius J; Schembri-Wismayer P
    Biomed Pharmacother; 2020 Oct; 130():110549. PubMed ID: 32726743
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Combined inhibition of menin-MLL interaction and TGF-β signaling induces replication of human pancreatic beta cells.
    Pahlavanneshan S; Behmanesh M; Oropeza D; Furuyama K; Tahamtani Y; Basiri M; Herrera PL; Baharvand H
    Eur J Cell Biol; 2020 Jun; 99(5):151094. PubMed ID: 32646642
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
    Shen E; Xiu J; Bentley R; López GY; Walsh KM
    Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
    Dhakal B; Patel S; Girnius S; Bachegowda L; Fraser R; Davila O; Kanate AS; Assal A; Hanbali A; Bashey A; Pawarode A; Freytes CO; Lee C; Vesole D; Cornell RF; Hildebrandt GC; Murthy HS; Lazarus HM; Cerny J; Yared JA; Schriber J; Berdeja J; Stockerl-Goldstein K; Meehan K; Holmberg L; Solh M; Diaz MA; Kharfan-Dabaja MA; Farhadfar N; Bashir Q; Munker R; Olsson RF; Gale RP; Bayer RL; Seo S; Chhabra S; Hashmi S; Badawy SM; Nishihori T; Gonsalves W; Nieto Y; Efebera Y; Kumar S; Shah N; Qazilbash M; Hari P; D'Souza A
    Leukemia; 2020 Dec; 34(12):3338-3347. PubMed ID: 32313109
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
    Ai H; Yin QS; Wang Q; Fu YW; Wei XD; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):239-244. PubMed ID: 32311895
    [No Abstract]    [Full Text] [Related]  

  • 16. [Expression and Significance of BTLA and Its Ligand HVEM in Patients with Chronic Myelomonocytic leukemia].
    Li C; Geng SX; Li MM; Su F; Chen XM; Deng CX; Huang X; Lai PL; Weng JY; DU X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):56-62. PubMed ID: 32027253
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The potential health gain and cost savings of improving adherence in chronic myeloid leukemia.
    Ector GICG; Govers TM; Westerweel PE; Grutters JPC; Blijlevens NMA
    Leuk Lymphoma; 2019 Jun; 60(6):1485-1492. PubMed ID: 30668187
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1.
    Bamodu OA; Kuo KT; Yuan LP; Cheng WH; Lee WH; Ho YS; Chao TY; Yeh CT
    Exp Cell Res; 2018 Sep; 370(2):519-530. PubMed ID: 30017934
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute leukemia through cdkn2c Repression.
    Lin CH; Wong SH; Kurzer JH; Schneidawind C; Wei MC; Duque-Afonso J; Jeong J; Feng X; Cleary ML
    Cell Rep; 2018 Apr; 23(4):1166-1177. PubMed ID: 29694893
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.